Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5-Reference-Cited by-同舟云学术

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Published:2008-01-01 Issue:3 Volume:42 Page:220-229
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Olov Hedlund Per¹,Damber Jan-Erik²,Hagerman Inger³,Haukaas Svein⁴,Henriksson Peter⁵,Iversen Peter⁶,Johansson Robert⁷,Klarskov Peter⁸,Lundbeck Finn⁹,Rasmussen Finn⁸,Varenhorst Eberhard¹⁰,Viitanen Jouko¹¹,Olov Hedlund Per¹,Damber Jan-Erik²,Hagerman Inger³,Haukaas Svein⁴,Henriksson Peter⁵,Iversen Peter⁶,Johansson Robert⁷,Klarskov Peter⁸,Lundbeck Finn⁹,Rasmussen Finn⁸,Varenhorst Eberhard¹⁰,Viitanen Jouko¹¹, ,

Affiliation:

1. Department of Urology, Karolinska University Hospital Solna, Sweden

2. Department of Urology, Sahlgrens University Hospital, Gothenburg, Sweden

3. Department of Cardiology, Karolinska University Hospital, Huddinge, Sweden

4. Diakonissehjemmet Hospital, Bergen, Norway

5. Department of Medicine, Danderyd University Hospital, Danderyd, Sweden

6. Department of Urology, Rigshospitalet, Copenhagen, Denmark

7. Oncologic Center, Umeå University Hospital, Umeå, Sweden

8. Department of Urology, Herlev University Hospital, Herlev, Denmark

9. Department of Urology, Skejby University Hospital, Aarhus, Denmark

10. Department of Urology, Linköping University Hospital, Linköping, Sweden

11. Department of Urology, North Karjala Central Hospital, Joensuu, Finland